XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Accrued Expenses
6 Months Ended
Jun. 30, 2018
Accrued Expenses [Abstract]  
Accrued Expenses

Note 4. Accrued Expenses

 

The following is a summary of the Company’s accrued expenses:

  

  June 30,
2018
  December 31,
2017
 
       
Clinical trial expenses $1,588,393  $1,011,666 
Other  141,512   131,640 
Total $1,729,905  $1,143,306